(Press-News.org) A team of researchers has made a significant discovery which may have a dramatic impact on children stricken with Tay-Sachs disease, a degenerative and fatal neurological condition that often strikes in the early months of life.
Available drugs may dramatically ease a child's suffering, say scientists.
"There is hope for this disease," says Suleiman Igdoura, lead researcher of the study and an associate professor of biology at McMaster University. "Imagine what that could mean for parents who have a child diagnosed with this incurable condition, who may have only a few years with their child."
Tay-Sachs is a genetic disorder caused by the absence of vital enzymes which are involved in the breakdown of waste within cells. Without those enzymes, waste accumulates and eventually destroys healthy cells, leading to blindness, paralysis, mental retardation and eventually death.
Igdoura and his team have found that when a key protein in the brain—known as TNFa—is removed, some of the devastating symptoms of Tay-Sachs and its close relative Sandhoff, were much less severe when tested in mice. Those symptoms include spasms, muscle wasting and loss of neurological function.
The findings are significant because the protein can be managed by FDA-approved drugs, readily available on the market.
"With Tay-Sachs and Sandhoff, we have very little to offer families in terms of therapeutics to help their children," says Igdoura.
"These are orphan diseases where there are not many medications available. But we feel this is a significant step in improving quality of life and quite possibly extending lives."
Children who are diagnosed with Tay-
Sachs early in life, typically die before they reach the age of four or five.
"There are distinct stages within the disease, so we wanted to find targets we could interfere with, to delay the terrible outcome or halt it altogether," explains Igdoura.
Using mice which were genetically altered to mimic Tay-Sachs and Sandhoff, researchers found levels of TNFa rose significantly during the early stages of the diseases.
But when TNFa was subsequently removed, there was a significant improvement in the lifespan of the mice and neurological function.
"We also found that neurons didn't die as early as they do with the disease, so we delayed the progression as well," says Igdoura. "We have identified a molecule that is the culprit and we believe there are drugs available to stop it."
The research is published online in the journal Human Molecular Genetics.
INFORMATION:
A high resolution photo of Suleiman Igdoura can be found at https://dl.dropboxusercontent.com/u/7319416/igdoura.zip.
For more information, please contact:
Michelle Donovan
Public Relations Manager
McMaster University
905-525-9140 ext. 22869
donovam@mcmaster.ca
Wade Hemsworth
Public Relations Manager
McMaster University
905-525-9140, ext. 27988
hemswor@mcmaster.ca
Readily-available drugs may reduce devastating symptoms of Tay-Sachs disease: Study
2013-06-06
ELSE PRESS RELEASES FROM THIS DATE:
Research unveils insight into a debilitating brain disease
2013-06-06
Athens, Ga. – From the neurons that enable thought to the keratinocytes that make toenails grow–a complex canopy of sugar molecules, commonly known as glycans, envelop every living cell in the human body.
These complex carbohydrate chains perform a host of vital functions, providing the necessary machinery for cells to communicate, replicate and survive. It stands to reason, then, that when something goes wrong with a person's glycans, something goes wrong with them.
Now, researchers at the University of Georgia are learning how changes in normal glycan behavior are ...
Vitamin D deficiency may help spread of hepatitis B throughout liver
2013-06-06
Researchers from Germany have found that low levels of vitamin D are associated with high levels of hepatitis B virus (HBV) replication. Findings published online in Hepatology, a journal of the American Association for the Study of Liver Diseases, suggest seasonal fluctuations in vitamin D and HBV levels point to a link in these variables among patients with chronic HBV.
While highly effective vaccines are available, HBV still remains one of the most significant infectious diseases worldwide. In fact, the World Health Organization (WHO) states that HBV is 50 to 100 ...
Study finds one in four patients with newly-diagnosed erectile dysfunction is a young man
2013-06-06
In a recent analysis of one outpatient clinic, one in four men seeking medical help for newly-developed erectile dysfunction (ED) was younger than 40 years, and nearly half of young men with the condition had severe ED. While larger population-based studies are needed, the findings, which were published in The Journal of Sexual Medicine, suggest that erectile dysfunction in young men may be more prevalent and more serious than previously thought.
Erectile dysfunction is a common complaint in men over 40 years of age. Prevalence increases with age, but the prevalence ...
UGA study shows current laws don't prevent Sub-Saharan 'land grabbing'
2013-06-06
Athens, Ga. – Sub-Saharan Africa has foreign investors flocking to buy its fertile land. Sometimes referred to as "land grabbing," the large-scale buying or leasing of large tracts of land in developing countries shifts indigenous, or customary, land rights from chiefs and local communities to investors or national governments, often stripping native people of a source of income.
The laws, its practices and eventual outcomes for the countries and people involved are the topic of one recent study led by University of Georgia anthropologist Laura German.
Looking at ...
Surgeons at Duke University Hospital implant bioengineered vein
2013-06-06
DURHAM, N.C. – In a first-of-its-kind operation in the United States, a team of doctors at Duke University Hospital helped create a bioengineered blood vessel and implanted it into the arm of a patient with end-stage kidney disease.
The procedure, the first U.S. clinical trial to test the safety and effectiveness of the bioengineered blood vessel, is a milestone in the field of tissue engineering. The new vein is an off-the-shelf, human cell-based product with no biological properties that would cause organ rejection.
Using technology developed at Duke and at a spin-off ...
Buckle up the right way: Motor vehicle child safety restraints
2013-06-06
ROSEMONT, Ill.—Supplemental child restraints should be used by all children through age 8. When appropriate child safety restraint systems—based on a child's age and weight—are in use during motor vehicle crashes, the rates of mortality and serious injury significantly decrease. Most parents don't know that their older children—ages 4 to 8—should use additional measures to protect them from serious injury or death in case of a crash.
In a literature review appearing in the June 2013 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), researchers ...
Excessive Facebook use can damage relationships, MU study finds
2013-06-06
COLUMBIA, Mo. -- Facebook and other social networking web sites have revolutionized the way people create and maintain relationships. However, new research shows that Facebook use could actually be damaging to users' romantic relationships. Russell Clayton, a doctoral student in the University of Missouri School of Journalism, found that individuals who use Facebook excessively are far more likely to experience Facebook–related conflict with their romantic partners, which then may cause negative relationship outcomes including emotional and physical cheating, breakup and ...
New screening method quickly identifies mice bred for bone marrow regeneration studies
2013-06-06
New Rochelle, NY, June 6, 2013— Immunocompromised mice, created by inactivating the genes that would allow them to recognize and attack donor cells or organs, are critical for studies of bone marrow reconstitution. A more rapid and reliable technique for identifying these mice in breeding colonies is described in an article in BioResearch Open Access, a peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers. The article is available free on the BioResearch Open Access website.
Alejandro Ferrer, Adam Schrum, and Diana Gil, College of Medicine, Mayo ...
NASA sees heavy rainfall in tropical storm Andrea
2013-06-06
NASA's TRMM satellite passed over Tropical Storm Andrea right after it was named, while NASA's Terra satellite captured a visible image of the storm's reach hours beforehand. TRMM measures rainfall from space and saw that rainfall rates in the southern part of the storm was falling at almost 5 inches per hour.
NASA's Terra satellite passed over Tropical Storm Andrea on June 5 at 16:25 UTC (12:25 p.m. EDT) and the Moderate Resolution Imaging Spectroradiometer or MODIS instrument, captured a visible image of the storm. At that time, Andrea's clouds had already extended ...
Mount Sinai discovers new liver cell for cellular therapy to aid in liver regeneration
2013-06-06
Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the 12th leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published in the online journal Cell Stem Cell today, suggests that it may one day become possible to regenerate a liver using cell therapy in patients with liver disease. Investigators discovered that a human embryonic stem cell can be differentiated into a previously unknown liver progenitor cell, an early offspring of a stem cell, and produce mature and functional ...